These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 786607)

  • 21. A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting.
    Roy P; Patel NH; Miller AJ
    Br J Clin Pract; 1991; 45(4):247-51. PubMed ID: 1810356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metoclopramide.
    Schulze-Delrieu K
    Gastroenterology; 1979 Oct; 77(4 Pt 1):768-79. PubMed ID: 223940
    [No Abstract]   [Full Text] [Related]  

  • 23. Some aspects of medical management of gastrointestinal disease. I.
    Badley BW
    Can Med Assoc J; 1975 Jan; 112(2):200-4, 206. PubMed ID: 234288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind crossover study of metoclopramide versus placebo for facilitating passage of multipurpose biopsy tube.
    Christie DL; Ament ME
    Gastroenterology; 1976 Nov; 71(5):726-8. PubMed ID: 786773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extrapyramidal type collateral effects of the administration of metoclopramide to children].
    Bruni L; Funaro G; Grilli MA; Bernardi S; Tozzi MC
    Pediatr Med Chir; 1989; 11(3):317-8. PubMed ID: 2594559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
    Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
    Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Nov; 24(5):360-400. PubMed ID: 6756878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP; Heel RC
    Drugs; 1985 Mar; 29(3):189-207. PubMed ID: 3886352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of intra-muscular metoclopramide on gastric emptying during labour.
    Howard FA; Sharp DS
    Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:53-7. PubMed ID: 4614246
    [No Abstract]   [Full Text] [Related]  

  • 32. [The employment of pharmacodynamic tests in the radiological examination of the digestive tract (author's transl)].
    Renda F; Lupini A; Bonomo L; Basilico L
    Radiol Med; 1978 Dec; 64(12):1345-51. PubMed ID: 754203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental study on bromopride pharmacology in vivo. antiemetic activity, effects on intestinal transit, on bloating and on gastric ulcers; basal effects on CNS and interferences with the spontaneous motor activity.
    Giordano L; Visone C; Rosatti R; Di Mezza G; Montanino C; Turtur A; Losanna Cannavacciuolo G
    Agressologie; 1980; 21(1):41-8. PubMed ID: 7235161
    [No Abstract]   [Full Text] [Related]  

  • 34. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
    Gu SF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Extrapyramidal signs as side-effect with metoclopramid-medication (author's transl)].
    Tobolka-Christian G
    Padiatr Padol; 1978; 13(4):425-8. PubMed ID: 714491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting.
    Dahl E; Diskin AL
    Int Marit Health; 2014; 65(1):16-9. PubMed ID: 24677122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
    McCallum RW; Valenzuela G; Polepalle S; Spyker D
    J Pharmacol Exp Ther; 1991 Jul; 258(1):136-42. PubMed ID: 2072291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Extrapyramidal reactions induced by intravenous metoclopramide].
    Martín Jiménez M; Díaz-Rubio García E; Castellón Leal E; Sánchez Sobrino M
    Med Clin (Barc); 1984 Sep; 83(8):352-3. PubMed ID: 6521555
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primperan: recent pharmacological data on its gastromotor effect].
    Frontenas P
    Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):15-6. PubMed ID: 4037708
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.